NIH Office of Research on Women's Health Grants (Assistance Listing 93.313)
Administered by National Institutes of Health. An Assistance Listing is the permanent catalog entry for a federal funding program — individual opportunities are issued under it and come and go.
Overview
Assistance Listing 93.313 — NIH Office of Research on Women's Health — is a federal funding program administered by National Institutes of Health. UseGrants has tracked 54 funding opportunities issued under it, of which 48 are accepting applications right now. A further 1 is forecast — announced by the agency but not yet open. The typical award ceiling is $499,000, with the largest at $6,250,000. Historically, opportunities under this listing post most often in April and May.
Eligibility is set per opportunity, not per listing. The free UseGrants check matches your organization type and focus against every open opportunity, including these.
- Open now
- 48
- Forecast
- 1
- Opportunities tracked
- 54
- Typical ceiling
- $499K
- Largest ceiling
- $6.3M
- Assistance Listing
- 93.313
Open opportunities under 93.313
48 opportunities are accepting applications, newest first. Confirm every detail on the issuing agency’s official listing before you apply.
NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25/UE5) funds mentoring activities and networks that develop the biomedical, behavioral, and clinical research workforce. It requires institutional commitment of staff, facilities, and resources, and proposed activities must be distinct from any existing federally funded training programs (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds hands-on research experiences that help build and diversify the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can provide the staff, facilities, and educational resources to run such programs, and proposed activities must be distinct from any existing federally funded training grants (such as T32). Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds the development of courses, curricula, and educational methods that strengthen the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can commit staff, facilities, and educational resources, and proposed activities must be distinct from any existing federally funded training grants (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityMaximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36 - Clinical Trial Not Allowed)
Due Oct 15, 2026National Institutes of Health · Amount varies
This NIH (NICHD) R36 dissertation grant supports individual doctoral candidates completing dissertation research in high-priority child health areas using data from the ECHO Cohort, a de-identified longitudinal dataset of more than 71,000 participants. Because it is a dissertation award, it is narrowly aimed at doctoral students (working through their institutions) in relevant scientific fields, not the general public or organizations broadly. Foreign organizations, the foreign components of U.S. organizations, and foreign components are not eligible or allowed. No specific award amount is stated; see the NOFO for full eligibility details.
ResearchersIndividualsSchools & universitiesNarrow eligibilityNIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Due Apr 5, 2027National Institutes of Health · Amount varies
This NIH STTR program (R41/R42) funds U.S. small businesses that partner with a nonprofit research institution to move scientific innovations toward commercialization. Eligibility is limited to U.S. small business concerns as defined by the SBA, and foreign organizations are not eligible. No award amount is listed.
Small businessNarrow eligibilityMaximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
Due Dec 2, 2026National Institutes of Health · Amount varies
NIH individual postdoctoral fellowship (F32) supporting a named postdoctoral fellow to analyze the ECHO program's longitudinal child-health dataset within the NICHD DASH repository. This is an individual fellowship awarded through a sponsoring US institution; foreign organizations are not eligible and foreign components are not allowed. No award amount is stated. It is restricted to eligible postdoctoral researchers at a US institution, so eligibility is narrow.
ResearchersIndividualsSchools & universitiesNarrow eligibilityNIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Due Apr 5, 2029National Institutes of Health · Amount varies
This NIH SBIR Phase IIB award is restricted to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award; it bridges the gap between Phase II and commercialization for later-stage R&D. Only one such award is allowed per project, and applications must be submitted within the first six due dates after the Phase II budget period ends, so it is narrow and limited to existing grantees. Foreign organizations are not eligible to apply.
Small businessNarrow eligibilitySBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Due Apr 5, 2029National Institutes of Health · Amount varies
This NIH SBIR/STTR Commercialization Readiness Pilot (CRP) is restricted to U.S. small business concerns (as defined by the SBA) and helps move NIH-funded SBIR/STTR projects from late-stage development toward commercialization. It supports later-stage R&D and technical assistance such as replication studies, IND/IDE-enabling work, clinical studies, manufacturing scale-up, and regulatory support, and a significant portion may be subcontracted. Foreign organizations are not eligible to apply.
Small businessNarrow eligibilityNIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Due Apr 5, 2027National Institutes of Health · Amount varies
This NIH/CDC/FDA SBIR program (R43/R44) funds U.S. small businesses developing scientific innovations toward commercial products through feasibility and R&D studies. Eligibility is limited to U.S. small business concerns as defined by the SBA, and foreign organizations are not eligible. No award amount is listed.
Small businessNarrow eligibilityNIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
The NIH Science Education Partnership Award (SEPA, R25) funds educational projects that increase understanding of biomedical research among pre-college (pre-K through grade 12) students and encourage interest in STEM careers. It suits universities, research institutions, and education-focused organizations that can run science education programs. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesNonprofitsNarrow eligibilityCommunity Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)
Due Oct 19, 2026National Institutes of Health · Amount varies
This NIH U01 cooperative agreement funds a single Community Engagement Evaluation and Data coordination (CEED) hub to support a community-based participatory research consortium focused on oral health, coordinating data planning, community engagement evaluation, and operational support. Clinical trials are not allowed, and as a cooperative agreement NIH staff are substantially involved. This is a narrow, single-hub coordination role rather than a broad research grant. Foreign organizations, the foreign components of U.S. organizations, and foreign components are not eligible or allowed; see the NOFO for full eligibility details. No award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityCommunity-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)
Due Nov 16, 2028National Institutes of Health · Up to $300K
This NIH UG3/UH3 cooperative agreement funds community-based participatory research that tests population-level interventions to improve oral health by addressing social and chronic-disease risk factors through cross-sector community partnerships. The award ceiling is up to about $300,000. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, and foreign components are not allowed.
ResearchersSchools & universitiesNonprofitsNarrow eligibilityOpportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
Due Mar 6, 2027National Institutes of Health · Up to $500K
An NIH U01 supporting collaborative translational research conducted with NIH intramural investigators using the NIH Clinical Center. Domestic and foreign organizations may apply, but NIH will not fund awards involving foreign subawards/subcontracts under this opportunity, so applications relying on foreign subawards are excluded. Awards reach up to about $500,000. This is a research grant for investigators able to partner with NIH, not for general nonprofits, small businesses, or individuals.
ResearchersSchools & universitiesLarge awardNarrow eligibilityAdministrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Due Nov 30, 2028National Institutes of Health · Amount varies
This NIH opportunity provides administrative supplements only to organizations that already hold an active, eligible NIH grant or cooperative agreement, to cover unforeseen increased costs within the scope of the existing project. New applicants without a current NIH award cannot use it. Funding is not guaranteed, and applicants must discuss requests with the awarding Institute's staff before submitting; foreign organizations may apply only consistent with the existing parent award.
ResearchersSchools & universitiesNarrow eligibilityStephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
Due Aug 25, 2028National Institutes of Health · Amount varies
Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R01 supports early-stage investigators pursuing a new research direction, and applications must include no preliminary data. Award size follows standard R01 limits; aimed at researchers early in their independent careers.
ResearchersSchools & universitiesNonprofitsGovernment / tribalShort Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)
Due Apr 9, 2027National Institutes of Health · Up to $200K
This NIH R25 supports short courses that teach innovative research methods in the behavioral and social sciences, aimed at developing the biomedical research workforce. Eligible applicants are research institutions such as universities and minority- or tribal-serving colleges, with foreign organizations excluded. Awards go up to $200,000.
ResearchersSchools & universitiesIntervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Due Jan 7, 2027National Institutes of Health · Amount varies
This NIH R01 funds larger-scale research testing and disseminating interventions to improve health in Native American populations, following the same research focus as its companion R34 announcement. Eligible applicants include universities, tribal colleges, minority-serving institutions, and community organizations, with foreign entities restricted. No award amount is specified.
ResearchersBroad eligibilityIntervention Research to Improve Native American Health (R34 Clinical Trial Optional)
Due Jan 7, 2027National Institutes of Health · Amount varies
This NIH R34 funds early-stage research and pilot studies testing interventions to improve health outcomes in Native American communities, including etiologic research and culturally-informed treatment studies. Eligible applicants include universities, tribal colleges, minority-serving institutions, and community organizations, with some restrictions on foreign entities. No award amount is specified; a clinical trial component is optional.
ResearchersBroad eligibilityEthical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
Due Nov 18, 2026National Institutes of Health · Amount varies
This NIH R01 grant funds research applications studying the ethical, legal, and social implications of human genetics and genomics, using empirical, conceptual, legal, or normative methods. Applications must include a Plan for Enhancing Diverse Perspectives (PEDP); those without one won't be reviewed. It's aimed at eligible U.S. and territorial research institutions, and the deadline is November 18, 2026.
ResearchersSchools & universitiesNarrow eligibilityEthical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
Due Nov 16, 2026National Institutes of Health · Up to $50K
This NIH grant (up to $50,000) funds small research projects studying the ethical, legal, and social implications (ELSI) of human genetics and genomics, including single-investigator studies, preliminary data collection, and secondary data analysis. It's aimed at eligible U.S. and territorial research institutions. The deadline is November 16, 2026.
ResearchersSmall awardNarrow eligibilityEthical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Due Nov 18, 2026National Institutes of Health · Amount varies
This NIH R21 grant funds exploratory and developmental research into the ethical, legal, and social implications of human genetics and genomics, particularly studies examining new or emerging genomic technologies. It's open to eligible U.S. and territorial research institutions using empirical, conceptual, legal, or normative methods. The deadline is November 18, 2026.
ResearchersSchools & universitiesNarrow eligibilityAcademic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $499K
An NIH/NCI research project grant (R01, clinical trial not allowed) funding academic-industrial partnerships to translate scientific and engineering advances into tools for disease risk assessment, detection, diagnosis, and treatment. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. The award is capped at about $499,000. The partnership focus suits research institutions collaborating with industry rather than individuals.
ResearchersSchools & universitiesGovernment / tribalNonprofits+2 moreLeveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
Due Nov 15, 2027National Institutes of Health · Up to $6.3M
This NIH award lets investigators use NICHD's existing clinical research network infrastructure to run multisite trials and studies on infant, child, women's, and disability health, structured as a start-up phase followed by full enrollment. Applications must be submitted jointly with an NICHD-supported network Data Coordinating Center, which narrows this to investigators already positioned within that network. Awards can reach up to $6,250,000.
ResearchersLarge awardNarrow eligibilityRisk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
Due May 8, 2027National Institutes of Health · Amount varies
This NIH R01 funds research on risk and protective factors in family health, well-being, and resilience, aimed at reducing health disparities through family-level interventions. Eligible applicants include universities, minority- and tribal-serving institutions, and community organizations, with restrictions on foreign entities. No award amount is specified.
ResearchersBroad eligibilityLimited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
Due Oct 19, 2027National Institutes of Health · Up to $650K
This NIH limited-competition award (UG3/UH3) funds collaborative innovation projects within the CTSA Program consortium to accelerate translational research. Eligibility is restricted per the funding notice, and foreign organizations and their U.S. components are not eligible, so this is aimed at institutions already in or aligned with the CTSA consortium rather than the general public. Awards run up to roughly $650,000. Review the notice's eligibility section closely, as access is limited.
ResearchersSchools & universitiesLarge awardNarrow eligibilityMood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH (R21) opportunity funds translational research into mood and psychosis symptoms during the menopause transition, examining underlying neurobiological and behavioral mechanisms. It targets research and academic institutions and interdisciplinary research teams, not individuals or typical nonprofits/small businesses. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityMood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH (R01) opportunity funds translational research into mood and psychosis symptoms during the menopause transition, including neurobiological and behavioral mechanisms and interdisciplinary collaboration. It targets research and academic institutions, not individuals or typical nonprofits/small businesses. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityScreening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH R01 funds studies testing innovative screening, brief intervention, and referral-to-treatment (SBIRT/P) approaches for alcohol, tobacco, and drug use in adult populations facing health disparities. Applicants should be research institutions collaborating with healthcare and community partners; eligible entities include universities, minority-serving institutions, and community organizations. No award amount is specified, and a clinical trial component is required.
ResearchersBroad eligibilityRuth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Due May 4, 2028National Institutes of Health · Amount varies
This NIH training grant funds domestic institutions of higher education (including HBCUs, Hispanic-serving institutions, and tribal colleges) to build predoctoral and postdoctoral biomedical research training programs, not individual researchers directly. Eligibility is fairly broad among institution types, but non-domestic entities and their foreign components are excluded, and the program does not support short-term-only training plans. No dollar amount is listed, and the deadline is not near-term.
Schools & universitiesBroad eligibilityEnhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
Due Jun 2, 2027National Institutes of Health · Amount varies
This NIH (R61/R33) phased opportunity funds mechanistic research to advance precision probiotic therapies, beginning with an exploratory phase to identify person-specific factors and a second phase to test them in animal models or human subjects, over a combined period of up to five years. Eligible applicants are U.S. research organizations including universities, government and tribal entities, and faith- or community-based organizations; foreign organizations and non-U.S. components are not eligible to apply, though some foreign components are allowed. Transition between phases depends on meeting milestones. It is intended for established research teams, not individuals or general nonprofits. Award amounts are not specified.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityEnhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Due Jun 2, 2027National Institutes of Health · Amount varies
This NIH (R33) opportunity funds mechanistic research to advance precision probiotic therapies by characterizing person-specific factors that affect probiotic responses, using animal models or human subjects. Eligible applicants are U.S. research organizations including universities, government and tribal entities, and faith- or community-based organizations; foreign organizations and non-U.S. components are not eligible to apply, though some foreign components are allowed. It expects supportive preliminary data and is intended for established research teams, not individuals or general nonprofits. Award amounts are not specified.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityEmerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
Due Dec 3, 2026National Institutes of Health · Amount varies
This NIH/Fogarty K43 career development award supports an early-career scientist at an academic or research institution in a low- or middle-income country, for research that does not involve leading an independent clinical trial. Eligibility is narrow and country-restricted: only foreign institutions in qualifying LMICs may apply, U.S. organizations and their foreign components are not eligible, and some upper-middle-income G20 countries are excluded. This is not available to U.S. applicants. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityEmerging Global Leader Award (K43 Independent Clinical Trial Required)
Due Dec 3, 2026National Institutes of Health · Amount varies
This NIH/Fogarty K43 career development award supports an early-career scientist at an academic or research institution in a low- or middle-income country, with a required independent clinical trial. Eligibility is narrow and country-restricted: only foreign institutions in qualifying LMICs may apply, U.S. organizations and their foreign components are not eligible, and some upper-middle-income G20 countries are excluded. This is not available to U.S. applicants. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityInterventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
Due Jan 7, 2027National Institutes of Health · Amount varies
This NIH R01 funds research testing interventions that expand cancer screening and preventive-service uptake in populations facing health disparities, ideally involving community partners. Eligible applicants include universities, minority- and tribal-serving institutions, and community-based organizations, but non-U.S. organizations and their foreign components are excluded. No award amount is specified; this is a research grant requiring a clinical trial component.
ResearchersBroad eligibilityMidcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH midcareer award (K24) provides protected time for mid-career clinician-scientists to conduct patient-oriented research and mentor junior clinical researchers; this version does not allow leading an independent clinical trial. It is intended for individual health-professional investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMidcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH midcareer award (K24) provides protected time for mid-career clinician-scientists to conduct patient-oriented research and mentor junior clinical researchers, and this version requires an independent clinical trial. It is intended for individual health-professional investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityIndependent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH Independent Scientist Award (K02) provides salary support and protected time for newly independent investigators to intensify their research focus; this version does not allow leading an independent clinical trial. It is intended for individual investigators applying through eligible institutions such as universities. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH mentored research scientist award (K01) provides three to five years of protected, supervised career development leading to research independence; this version does not allow leading an independent clinical trial. It is intended for individual investigators applying through eligible institutions such as universities. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityNIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH Pathway to Independence award (K99/R00) supports outstanding postdoctoral researchers transitioning to independent faculty positions; this version does not allow leading an independent clinical trial. It is intended for individual early-career investigators applying through eligible institutions such as universities; foreign organizations cannot apply. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
Due May 8, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K08) prepares individuals with a clinical doctoral degree for research careers through supervised biomedical, behavioral, or translational research; this version does not allow leading an independent clinical trial. It is intended for individual clinician-investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityIndependent Scientist Award (Parent K02 - Independent Clinical Trial Required)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH Independent Scientist Award (K02) provides salary support and protected time for newly independent investigators to intensify their research focus, and this version requires leading an independent clinical trial. It is intended for individual investigators applying through eligible institutions such as universities. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH mentored research scientist award (K01) provides three to five years of protected, supervised career development in biomedical, behavioral, or clinical research leading to independence, and this version requires an independent clinical trial. It is intended for individual investigators applying through eligible institutions such as universities. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)
Due May 8, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K08) prepares individuals with a clinical doctoral degree for research careers through supervised biomedical, behavioral, or translational research, and this version requires an independent clinical trial. It is intended for individual clinician-investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityNIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
Due May 7, 2027National Institutes of Health · Amount varies
The NIH K99/R00 Pathway to Independence Award supports postdoctoral researchers transitioning to independent faculty positions, covering a mentored phase followed by several years of independent research funding. Applications are submitted through eligible research institutions — universities, minority-serving colleges, and similar organizations — on behalf of the individual awardee. No award amount is specified, and a clinical trial component is required for this version.
ResearchersBroad eligibilityMentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
The NIH K25 award supports quantitative scientists and engineers (e.g., in math, statistics, computer science, or physics) who want to redirect their research toward NIH-relevant health questions, providing protected time for mentored study. It's submitted through eligible research institutions on behalf of an individual investigator, and excludes those leading an independent clinical trial. No award amount is specified.
ResearchersBroad eligibilityMentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K25) supports quantitative or engineering scientists redirecting their work toward health research, providing protected research time under a mentor; this version requires the applicant to lead an independent clinical trial. It is intended for individual investigators applying through eligible institutions such as universities. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)
Due May 8, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K23) supports individuals with a clinical doctoral degree committed to patient-oriented research, providing protected research time under mentorship, and this version requires an independent clinical trial. It is intended for individual clinician-investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K23) supports individuals with a clinical doctoral degree who are committed to patient-oriented research, providing protected research time under mentorship. This version does not allow leading an independent clinical trial. It is intended for individual clinician-investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibility
Forecast opportunities under 93.313
1 opportunity has been announced by the issuing agency but is not accepting applications yet. Forecast notices usually carry no deadline and no application package until they post.
| Anticipated opportunity | Award range | Expected close |
|---|---|---|
| NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed) | Amount varies | Not announced |
Previously issued under this listing
Past rounds are the best guide to what the next one will look like — the scope, the award size, and the time of year it lands.
When 93.313 opportunities post
Across the 54 opportunities UseGrants has tracked under this listing, postings cluster in April, May, November, June. Federal program cycles repeat, so a listing that missed you this year is worth watching for the next round.
- April16 opportunities
- May8 opportunities
- November7 opportunities
- June6 opportunities
What is Assistance Listing 93.313?
93.313 is the federal Assistance Listing (formerly CFDA) number for NIH Office of Research on Women's Health, administered by National Institutes of Health. An Assistance Listing is the permanent catalogue entry for a funding program; individual notices of funding opportunity are issued under it, each with its own deadline and eligibility. UseGrants has tracked 54 such notices.
Are there open 93.313 grants right now?
Yes — 48 opportunities are currently accepting applications under 93.313, listed on this page with their deadlines and award amounts. 1 more is forecast: announced, but not yet open to applicants. Verify each on the issuing agency's official listing before you apply.
How much funding do 93.313 grants award?
The typical award ceiling for an opportunity under 93.313 is $499,000, ranging up to $6,250,000. Award floors and ceilings are set per opportunity — check the specific notice you intend to apply to.
Which agencies issue grants under 93.313?
National Institutes of Health has issued the opportunities UseGrants tracks under this listing. UseGrants is an independent aggregator compiling public Grants.gov records — always confirm current details on the agency's own listing.
Who applies to 93.313, and what it sits alongside
Related federal programs
Source: public Grants.gov opportunity records. Assistance Listing numbers and program titles are as published by the issuing agency. UseGrants is an independent aggregator, not a federal agency — always confirm the current deadline, eligibility and award amount on the official listing before you apply.